Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1989 2
1990 1
1995 1
2003 2
2005 1
2006 1
2009 1
2014 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Yersinia enterocolitica endocarditis: case report and literature review.
Giamarellou H, Antoniadou A, Kanavos K, Papaioannou C, Kanatakis S, Papadaki K. Giamarellou H, et al. Among authors: kanatakis s. Eur J Clin Microbiol Infect Dis. 1995 Feb;14(2):126-30. doi: 10.1007/BF02111871. Eur J Clin Microbiol Infect Dis. 1995. PMID: 7758478 Review.
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.
Foster GR, Coppola C, Derbala M, Ferenci P, Orlandini A, Reddy KR, Tallarico L, Shiffman ML, Ahlers S, Bakalos G, Hassanein T; GUARD-C Study Group. Foster GR, et al. PLoS One. 2016 Mar 28;11(3):e0151703. doi: 10.1371/journal.pone.0151703. eCollection 2016. PLoS One. 2016. PMID: 27018988 Free PMC article. Clinical Trial.
Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study.
Manesis EK, Papatheodoridis GV, Touloumi G, Karafoulidou A, Ketikoglou J, Kitis GE, Antoniou A, Kanatakis S, Koutsounas SJ, Vafiadis I; HEPNET.Greece Cohort Study. Manesis EK, et al. Among authors: kanatakis s. Aliment Pharmacol Ther. 2009 May 15;29(10):1121-30. doi: 10.1111/j.1365-2036.2009.03974.x. Epub 2009 Feb 15. Aliment Pharmacol Ther. 2009. PMID: 19222410 Free article.
The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha-2b plus ribavirin treatment of naive and nonresponder chronic hepatitis C patients.
Raptopoulou M, Tsantoulas D, Vafiadi I, Ketikoglou I, Paraskevas E, Vassiliadis T, Kanatakis S, Hatzis G, Sidiropoulos L, Akriviadis E. Raptopoulou M, et al. Among authors: kanatakis s. J Viral Hepat. 2005 Jan;12(1):91-5. doi: 10.1111/j.1365-2893.2005.00549.x. J Viral Hepat. 2005. PMID: 15655054
Hepatitis C virus survival curve analysis in naïve patients treated with peginterferon alpha-2b plus ribavirin. A randomized controlled trial for induction with high doses of peginterferon and predictability of sustained viral response from early virologic data.
Mimidis K, Papadopoulos VP, Elefsiniotis I, Koliouskas D, Ketikoglou I, Paraskevas E, Kanatakis S, Chrysagis D, Dalekos GN, Tzathas C, Protopapas A, Gigi E, Tsianos E, Kartalis G. Mimidis K, et al. Among authors: kanatakis s. J Gastrointestin Liver Dis. 2006 Sep;15(3):213-9. J Gastrointestin Liver Dis. 2006. PMID: 17013444 Free article. Clinical Trial.
A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naïve patients with chronic hepatitis C.
Tassopoulos NC, Ketikoglou I, Tsantoulas D, Raptopoulou M, Hatzis G, Vafiadis I, Sidiropoulos L, Kanatakis S, Anagnostopoulos G, Sypsa V, Hatzakis A; Hellenic Viral Hepatitis Research Network. Tassopoulos NC, et al. Among authors: kanatakis s. J Viral Hepat. 2003 Sep;10(5):383-9. doi: 10.1046/j.1365-2893.2003.00439.x. J Viral Hepat. 2003. PMID: 12969190 Clinical Trial.
A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1.
Tassopoulos NC, Tsantoulas D, Raptopoulou M, Vassiliadis T, Kanatakis S, Paraskevas E, Vafiadis I, Avgerinos A, Tzathas C, Manolakopoulos S, Ketikoglou I, Aggelis P, Goritsas K, Giannoulis G, Hatzis G G, Thomopoulos K, Akriviadis E, Sypsa V, Hatzakis A. Tassopoulos NC, et al. Among authors: kanatakis s. J Viral Hepat. 2003 May;10(3):189-96. doi: 10.1046/j.1365-2893.2003.00406.x. J Viral Hepat. 2003. PMID: 12753337 Clinical Trial.
Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study.
Anagnostou O, Manolakopoulos S, Bakoyannis G, Papatheodoridis G, Zisouli A, Raptopoulou-Gigi M, Manesis E, Ketikoglou I, Dalekos G, Gogos C, Vassiliadis T, Tzourmakliotis D, Karatapanis S, Kanatakis S, Zoumpoulis -, Hounta A, Koutsounas S, Giannoulis G, Tassopoulos N, Touloumi G. Anagnostou O, et al. Among authors: kanatakis s. Hippokratia. 2014 Jan;18(1):57-64. Hippokratia. 2014. PMID: 25125954 Free PMC article.
12 results